Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 4,367 | 8,195 | 9,049 | 8,642 | 8,317 |
| Operating Income | -4,367 | -8,195 | -9,049 | -8,642 | -8,317 |
| Interest Expense | -231 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 259 | 317 | 380 | 237 |
| Pre-tax Income | -4,136 | -7,936 | -8,732 | -8,262 | -8,080 |
| Income Tax | -55 | 34 | 21 | 10 | N/A |
| Net Income Continuous | -4,081 | -7,970 | -8,753 | -8,272 | -8,080 |
| Net Income | $-4,081 | $-7,970 | $-8,753 | $-8,272 | $-8,080 |
| EPS Basic Total Ops | -1.36 | -2.88 | -3.20 | -2.93 | -2.80 |
| EPS Basic Continuous Ops | -1.38 | -2.88 | -3.17 | -2.93 | -2.83 |
| EPS Diluted Total Ops | -1.36 | -2.88 | -3.20 | -2.93 | -2.80 |
| EPS Diluted Continuous Ops | -1.38 | -2.88 | -3.17 | -2.93 | -2.83 |
| EBITDA(a) | $-4,348 | $-8,179 | $-9,033 | $-8,628 | $-8,300 |